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ABSTRACT
Objective The first observational study to investigate the 
impact of early supported discharge (ESD) on length of 
hospital stay in real- world conditions.
Design Using historical prospective Sentinel Stroke 
National Audit Programme (SSNAP) data (1 January 
2013–31 December 2016) and multilevel modelling, cross- 
sectional (2015–2016; 30 791 patients nested within 55 
hospitals) and repeated cross- sectional (2013–2014 vs 
2015–2016; 49 266 patients nested within 41 hospitals) 
analyses were undertaken.
Setting Hospitals were sampled across a large 
geographical area of England covering the West and East 
Midlands, the East of England and the North of England.
Participants Stroke patients whose data were entered 
into the SSNAP database by hospital teams.
Interventions Receiving ESD along the patient care 
pathway.
Primary and secondary outcome measures Length of 
hospital stay.
Results When adjusted for important case- mix variables, 
patients who received ESD on their stroke care pathway 
spent longer in hospital, compared with those who did not 
receive ESD. The percentage increase was 15.8% (95% 
CI 12.3% to 19.4%) for the 2015–2016 cross- sectional 
analysis and 18.8% (95% CI 13.9% to 24.0%) for the 
2013–2014 versus 2015–2016 repeated cross- sectional 
analysis. On average, the increased length of hospital stay 
was approximately 1 day.
Conclusions This study has shown that by comparing 
ESD and non- ESD patient groups matched for important 
patient characteristics, receiving ESD resulted in a 1- day 
increase in length of hospital stay. The large reduction in 
length of hospital stay overall, since original trials were 
conducted, may explain why a reduction was not observed. 
The longer term benefits of accessing ESD need to be 
investigated further.
Trial registration number http://www. isrctn. com/ 
ISRCTN15568163.
INTRODUCTION
Stroke is one of the main causes of adult 
disability, and there is strong research 
evidence that provision of stroke specialist 
rehabilitation enhances recovery.1 Stroke 
early supported discharge (ESD) is a 
multidisciplinary team intervention aimed 
at facilitating discharge from hospital and 
providing stroke specialist rehabilitation at 
home.2 Based on cumulative evidence from 
clinical trials, stroke care guidelines in the 
UK and worldwide recommend the provision 
of ESD as part of an evidence- based stroke 
care pathway.3–8
In many high- income countries, ESD has 
not been well developed in practice with a lack 
of large- scale implementation.9 In contrast, 
in the UK, considerable efforts have been 
made to implement ESD, although types of 
service differ across the country, and in some 
regions, ESD is still not offered at all.10 Where 
ESD has been delivered, it is unclear whether 
benefits of the ESD intervention, as suggested 
in clinical trials, are achieved in practice.
One of the attractive features of the ESD 
intervention as reported in clinical trials has 
been reduction in length of hospital stay, 
with the most recent Cochrane systematic 
review suggesting a reduction of 6 days.2 This 
reduction has contributed to the reported 
cost- effectiveness of combined stroke unit 
Strengths and limitations of this study
 ► First observational study comparing length of hos-
pital stay in real- world settings for patients access-
ing early supported discharge (ESD) compared with 
those that did not.
 ► Use of datasets from the Sentinel Stroke National 
Audit Programme (SSNAP), permitting sample sizes 
of 30 791 and 49 266 patients.
 ► Accounts for the variation that exists between pa-
tients clustered within their admitting hospitals by 
employing a multilevel modelling approach and 
reinforces group comparisons using a propensity 
score matching process.
 ► Unable to account for residual confounding.
 ► Did not investigate the longer term benefits of ac-
cessing ESD.
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care and ESD.11 Small- scale evaluation of ESD operating 
in localised areas have suggested smaller, but significant, 
reductions in length of acute hospital stay, but it remains 
unknown what impact ESD is having over a larger scale.12 
Average length of hospital stay for all stroke patients 
discharged alive fell from 40 days in 2001 to 20 days in 
2013 and has remained around this level since then.13 
This trend over time has meant more stroke unit beds 
are available for new patients, but it has also increased 
demand for patient care in the community posthospital 
discharge.
The Sentinel Stroke National Audit programme 
(SSNAP) is the national stroke register of England, 
Wales and Northern Ireland in which all acute admit-
ting hospitals and postacute stroke teams are mandated 
to participate.14 SSNAP has played a key role in moni-
toring performance and improving provision of acute 
stroke care. Collection of SSNAP data across the stroke 
care pathway now offers a unique opportunity to inves-
tigate the large- scale impact of postacute interventions 
such as ESD. The study reported here, and in a parallel 
paper exploring the effectiveness of ESD service models, 
investigates if trial- based benefits of ESD are realised in 
practice, with the aim to inform evidence based improve-




We present results from an observational cohort study 
(figure 1), conducted as part of an overall mixed method 
study.16 Data access requests should be directed to 
Healthcare Quality Improvement Partnership as the data 
controller and SSNAP as the data provider. The study 
protocol including statistical analysis plan is available 
online.16 We determined a priori a sample size of 21 760 
patients for a study power of 80% to detect standardised 
effect sizes of 0.25 for each outcome.
In this paper, we have used two different study designs: 
(1) a cross- sectional analysis (SSNAP data from 2015 
to 2016 time period) comparing length of hospital stay 
between patients who did and did not have ESD on their 
care pathway, with adjustment for hospital and individual 
confounding factors; and (2) repeated cross- sectional 
analysis using two sets of SSNAP data (2013–2014 and 
2015–2016) to establish whether length of hospital stay 
changed over time and whether any change was attribut-
able to ESD.
Setting
Hospitals (and associated ESD services) were sampled 
across a large geographical area of England. The 
sampling strategy was devised in accordance with the 
overall mixed method study design and included all ESD 
services in specific regions of England.16 Here we report 
findings from the quantitative investigation of ESD effect 
on length of hospital stay across West and East Midlands 
and East of England (across which a specific initiative to 
promote ESD was initiated in 2010) and the North of 
England, a region with a defined lack of ESD.10 17 We have 
included all main referring hospitals within the defined 
geographical area as well as referring hospitals whose 
patients did (or did not) go onto receive ESD along their 
care pathway within the catchment area.
Data sources and participants
Patient- level SSNAP data are entered by clinical teams onto 
a secure webtool with real- time data validations to ensure 
data quality.14 Historical prospective clinical (patient- 
level) SSNAP data were obtained from the SSNAP team 
with permission from Healthcare Quality Improvement 
Partnership. The first study design involved 55 admitting 
hospitals and SSNAP data for all patients admitted during 
1 September 2015–31 December 2016 (31 556 stroke 
patients). The second study design included 41 admitting 
hospitals, which were those of the 55 hospitals for which 
Figure 1 Study design flow chart. ESD, early supported 
discharge; LOS, length of stay; RCS, repeated cross- 
sectional; SSNAP, Sentinel Stroke National Audit Programme; 
WISE, What is the Impact of Stroke Early supported 
discharge?
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we could obtain SSNAP data for all patients admitted 
during two time periods, 1 September 2013–31 December 
2014 and 1 September 2015–31 December 2016 (50 793 
stroke patients).
Outcomes
Length of hospital stay was defined as the total length of 
hospital stay per patient (as an inpatient) from arrival at 
the admitting hospital (or time of stroke onset, if already 
an inpatient) to the time of discharge from the last inpa-
tient setting, including time spent at any other inpatient 
setting. Owing to the positive skewness of the underlying 
distribution, length of hospital stay was natural log trans-
formed before undertaking the statistical modelling, 
and all effect sizes were exponentiated afterwards to aid 
interpretation.
Confounding factors
In order to investigate the effect of ESD on length of 
hospital stay, we identified a need to control for the 
overall standard of hospital care and also the influence of 
provision of social care. At the hospital level, we included 
two confounding variables: a hospital SSNAP rating score 
and a measure of delayed transfers of care from hospital, 
derived from the Adult Social Care Outcomes Framework 
(ASCOF).
The hospital rating scores used in this study were an 
overall quality rating for each hospital obtained from 
SSNAP (total key indicator score derived across 10 
domains of stroke care with adjustments made for case 
ascertainment levels and the quality of data submitted to 
SSNAP).18 SSNAP produced performance rating scores 
for admitting hospitals during the periods of interest, and 
we used the score produced during the latter part of the 
period of interest for each analysis.19 This score for each 
admitting hospital was used as an indication of the overall 
standard of inpatient care after the onset of stroke. The 
ASCOF data report the average daily rate of delayed 
transfers of care per 100 000 population aged 18 years 
and over at local authority level. Data were aggregated 
up to National Health Service Trust level, using averages 
where multiple local authorities were associated with one 
National Health Service Trust. Again we focused on the 
scores produced during the latter part of the period of 
interest in line with the SSNAP hospital performance 
ratings.20
In order to account for comparison between different 
groups of individual patients, we also included variables 
at the patient level. These were stroke patient charac-
teristics, reflecting validated stroke case- mix models 
and collected as part of the SSNAP data set. These 
were age at admission, sex, prestroke independence, 
cardiovascular comorbidities, National Institutes of 
Health Stroke Scale (NIHSS) score on admission, type 
of stroke and modified Rankin Scale score at discharge 
from hospital.21 22
Statistical analyses
We employed a linear multilevel model framework for 
both study designs whereby patients (level 1) were clus-
tered within admitting hospitals (level 2) in an approach 
consistent with previous observational studies of this 
type.15 21–24 Within our multilevel models, we adjusted for 
a range of patient and hospital characteristics as covari-
ates. We chose multilevel modelling to evaluate the effect 
of ESD on length of hospital stay as it could accommo-
date and appreciate the variation that existed within and 
between different admitting hospitals. Furthermore, 
the intraclass correlation coefficient was calculated as a 
measure of proportion of the total variance in length of 
hospital stay, which was attributable to variance within 
admitting hospitals as opposed to between admitting 
hospitals.
The adequacy of different statistical models was 
compared using the log- likelihood, Akaike Information 
Criterion and Bayesian Information Criterion values 
from single level and multilevel regression models with 
multilevel preferable on each occasion. Multicollinearity 
was investigated by examining variance inflation factor 
scores of all predictor variable sets and was found not 
to be an issue. Covariate linearity was examined by 
checking the consistency of a linear trend in relation to 
each outcome variable. Regarding the impact of missing 
data, we assessed the mean change in the outcome vari-
able between the ESD and non- ESD groups in relation 
to missing predictor data (which amounted to a loss of 
0.6% of the total sample size); no substantial differences 
were found as we observed a mean difference of less than 
0.3%.
Analysis of cross-sectional data from 2015 to 2016
A quasiexperimental cross- sectional design was used in 
which patients who received ESD on their care pathway 
were compared with patients that had not (non- ESD). 
Hence, across 55 admitting hospitals covering the 1 
September 2015–31 December 2016 data period, we 
investigated the effect of ESD being on the care pathway 
(yes/no) for patients who had a stroke on their total 
length of hospital stay from admitting hospital until being 
discharged from the last inpatient setting.
Analysis of repeated cross-sectional data from 2013 to 2014 
and from 2015 to 2016
This analysis was to establish whether length of hospital 
stay changed over time, that is, between the earlier (1 
September 2013–31 December 2014) and later time 
periods (1 September 2015–31 December 2016), and 
whether any change was attributable to ESD, as ESD 
provision was higher in the later time period.10 Patients 
formed distinct groups over the two time periods as they 
were either admitted in the 2013–2014 time period or the 
2015–2016 time period with no patient covering both time 
periods.25 The same multilevel model approach was used 
as in the cross- sectional analysis and also incorporating 
an effect of time (13/14 or 15/16) and an interaction 
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between time and the effect of ESD, which modelled 
whether the effect of ESD was similar in the two time 
periods. The main effect of receiving ESD (with adjust-
ment for time) indicated the effect of ESD on length 
of hospital stay in the first time period. An interaction 
between time and ESD would indicate whether there was 
any difference in the effect of ESD on length of hospital 
stay between the first and second time periods.
Sensitivity analysis using propensity score matching
Since it was important to ensure that the effects of ESD 
were not the result of potential confounding factors, 
we also used an alternative method of controlling for 
confounders, that is, propensity score matching, as a 
sensitivity analysis. Propensity score matching involved 
matching patients with ESD on their pathway with similar 
patients who did not, based on their patient characteris-
tics. In this case, we explored two alternative approaches 
to propensity score matching, first matching patients with 
ESD to patients without ESD in the same hospital, that is, 
within- admitting hospital matching.26 This resulted in a 
truncated sample size as only hospitals with both ESD and 
non- ESD patients could contribute to this first matching 
analysis.
Second, we then allowed the matching to occur with 
similar patients without ESD in different hospitals, that 
is, between- admitting hospital matching.27 This second 
approach enabled us to use a larger sample size as all 
hospitals could contribute to the probability estimate 
of whether a patient received ESD or not regardless of 
what their patients actually received. In order to ensure 
greater accuracy in the latter analysis, we used a stratified 
matching process so that patients were only matched to 
patients in a hospital with a similar proportion of patients 
having access to ESD.
A two- tailed significance level of 0.05 was used in all 
hypothesis tests. We carried out the majority of anal-
yses using Stata/SE V.15.1, and the R package Matching 
was used to undertake the between- admitting hospital 
propensity score matching.
Patient and public involvement
The design and conduct of this study was informed 
through discussion with the Nottingham Stroke Partner-
ship group. Two stroke survivor members were part of the 
study steering group and advised on a lay summary of our 
study findings.
RESULTS
Analysis of cross-sectional data from 2015 to 2016
Table 1 presents descriptive statistics of the patient and 
admitting hospital level variables and the median number 
of days spent as an inpatient disaggregated by patients who 
received ESD (ESD; n=8648) or not (non- ESD; n=22 908) 
on the care pathway. Compared with patients who did not 
receive ESD, those who did were younger and more likely 
to be independent (lower premorbid modified Rankin 






  <60 1422 (16.4) 3674 (16.0)
  60–69 1692 (19.6) 3932 (17.2)
  70–79 2646 (30.6) 6080 (26.5)
  80–89 2373 (27.4) 6873 (30.0)
  >89 515 (6.0) 2349 (10.3)
Gender
  Male 4869 (56.3) 11 785 (51.4)
Already inpatient at 
time of stroke
  Yes 264 (3.1) 995 (4.3)
Congestive heart 
failure prior to 
admission
  Yes 348 (4.0) 994 (4.3)
Hypertension prior to 
admission
  Yes 4743 (54.9) 12 299 (53.7)
Atrial fibrillation prior 
to admission
  Yes 1370 (15.8) 4016 (17.5)
Diabetes prior to 
admission
  Yes 1770 (20.5) 4834 (21.1)
Stroke/TIA prior to 
admission
  Yes 2075 (24.0) 6100 (26.6)
Modified Rankin Scale 
score before stroke
  0 5688 (65.8) 12 796 (55.9)
  >0 2960 (34.2) 10 112 (44.1)
NIHSS score on arrival
  0 1041 (12.0) 3267 (14.3)
  1–5 4640 (53.7) 11 252 (49.1)
  6–14 2253 (26.1) 5596 (24.4)
  15–24 636 (7.4) 2322 (10.1)
  >24 78 (0.9) 471 (2.1)
Type of stroke
  Infarction 7804 (90.8) 20 772 (91.2)
  Primary intracerebral 
haemorrhage
789 (9.2) 2002 (8.8)
Modified Rankin Scale 
score at inpatient 
discharge
  0 1046 (12.1) 4016 (17.5)
  1 2259 (26.1) 5024 (21.9)
  2 1928 (22.3) 3420 (14.9)
Continued
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Scale score) before stroke as well as more independent at 
inpatient discharge (lower postmorbid modified Rankin 
Scale score). ESD patients were also more likely to have 
been admitted to a hospital with a higher SSNAP score 
rating and higher rate of delayed transfers.
Before adjustment, ESD patients had a longer length 
of hospital stay than non- ESD patients (median 6.9 (IQR: 
2.9–18.8) compared with 6.0 days (IQR: 2.2–24.8)). 
Following multilevel model analysis, after controlling 
for patient and hospital level characteristics, the mean 
length of stay for patients who received ESD along 
their care pathway compared with those who did not, 
remained significantly longer by 15.8% (95% CI 12.3% 
to 19.4%) (table 2). Similarly, from the sensitivity analysis 
using propensity score matching, patients who received 
ESD on their care pathway, on average, stayed in hospital 
longer (when controlling for all other patient character-
istics, and hospital SSNAP and ASCOF scores) (table 3). 
The within- admitting hospital propensity score matching 
process (n=10 449) suggested ESD patients stayed in 
hospital longer by an average of 8.7% (95% CI 4.8% to 
12.6%). The between- admitting hospital propensity score 
matching process (n=30 791) found that ESD patients 
stayed in hospital longer by an average of 7.3% (95% CI 
3.0% to 11.8%).
Analysis of repeated cross-sectional data from 2013 to 2014 
and from 2015 to 2016
Table 4 presents descriptive statistics of the patient and 
admitting hospital level variables used in the repeated 
cross- sectional analysis, as well as the median number of 
days spent as an inpatient disaggregated by patients who 
received ESD (n=11 376) or not (non- ESD; n=39 417) 
on the care pathway across the two time periods. This 
descriptive repeated cross- sectional analysis showed that 
the numbers of patients who received ESD significantly 
increased over the two time periods. Moreover, across the 
two time periods, ESD patients were younger, more likely 
to be male and more likely to have premorbid indepen-
dence, as evidenced by a lower modified Rankin Scale 
score. Before adjustment, ESD patients were recorded 
as having a longer length of stay in hospital than non- 
ESD patients (median 7.7 (IQR: 3.2–23.8) compared 
with 6.3 days (IQR: 2.5–22.1) in 2013–2014 and 6.8 (IQR: 
2.9–18.5) compared with 5.7 days (IQR: 2.1–24.6) in 
2015–2016).
Table 5 presents the results from the linear multilevel 
model. Again, we controlled for patient characteristics, 
SSNAP admitting hospital score and average ASCOF 
rates for each admitting hospital. There was no signifi-
cant interaction between receiving ESD and time period 
(p=0.79) so that the effect of ESD was similar in both 
time periods, despite more patients accessing ESD over 
time. Therefore, the main effect of ESD across both time 
periods was estimated to increase length of hospital stay by 
an average of 18.8% (95% CI 13.9% to 24.0%) compared 
with patients who did not receive ESD on their care 
pathway. Furthermore, the main effect of the 2015–2016 





  3 2189 (25.3) 3838 (16.8)
  4 1118 (12.9) 4154 (18.1)
  5 108 (1.3) 2456 (10.7)
Median (IQR) total 
length of hospital stay 
in days
6.9 (2.9–18.8) 6.0 (2.2–24.8)
Values are numbers (percentages) unless stated otherwise.
ESD, early supported discharge; NIHSS, National Institutes of 
Health Stroke Scale; TIA, transient ischemic attack.
Table 1 Continued
Table 2 Association between having received ESD on the care pathway and inpatient length of stay 2015–2016
Inpatient length of stay models Unadjusted Adjusted*
Patients 30 975 30 791
Admitting hospitals 55 55
Patients per admitting hospital
  Min 27 26
  Mean 563.2 559.8
  Max 1331 1310
Intraclass correlation coefficient 0.05 0.08
ESD on the care pathway Coefficient (95% CI) P value Coefficient (95% CI) P value
Received ESD 0.08 (0.04 to 0.12) <0.001 0.15 (0.12 to 0.18) <0.001
Model coefficients are on the natural log scale; significant results were back- transformed, that is, exponentiated to obtain percentage change 
in length of hospital stay (reported in text).
*Adjusted for age, sex, prestroke independence, comorbidities, NIHSS score on admission, type of stroke and modified Rankin Scale score at 
discharge from hospital (patient level); ASCOF rate and hospital SSNAP rating score (admitting hospital level).
ASCOF, Adult Social Care Outcomes Framework; ESD, early supported discharge; NIHSS, National Institutes of Health Stroke Scale; SSNAP, 
Sentinel Stroke National Audit Programme.
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was found to significantly reduce the length of hospital 
stay by an average of 14.0% (95% CI 12.2% to 15.9%).
The degree of clustering was low in both adjusted multi-
level models (adjusted intraclass correlation coefficients, 
were 0.08, 0.08 respectively) implying that the total vari-
ance we observed in the length of hospital stay data was 
more greatly accounted for by the patients than by the 
admitting hospitals.
DISCUSSION
This study has investigated the effect of ESD on length of 
hospital stay in real- world settings, with the aim to inform 
evidence- based improvements in stroke care. Unadjusted 
findings indicated that patients who had a stroke who 
received ESD spent approximately 1 day longer in hospital 
than all other patients; however, those who received ESD 
differed in characteristics from those who did not. With 
adjustment using two different designs and alternative 
analyses for the differing case- mix, length of hospital stay 
remained longer for those who received ESD on their 
care pathway. This contrasts with findings from original 
ESD randomised controlled trials, in which a reduction 
in length of hospital stay was reported.2
This is an important finding, particularly when consid-
ering implementation of ESD in practice. The promise 
of reducing length of hospital stay made ESD attractive 
with regard to cost savings and is likely to have contrib-
uted to widespread implementation in England.10 11 The 
economic implications of ESD in the real world have 
previously been investigated through simulation model-
ling (informed by SSNAP data similar to data used 
here).28 The authors reported an estimated mean length 
of hospital stay for ESD patients that was 8 days less than 
non- ESD patients and thereby derived cost savings associ-
ated with modelling increased use of ESD.
However, an important difference with that economic 
analysis and the study reported here relates to the fact 
that we used actual and total inpatient length of stay data 
combining different inpatient settings where applicable 
on a per- patient basis. Analysis showed that ESD patients 
were younger and more likely to have a lower modified 
Rankin Scale score at inpatient discharge. The simulation 
modelling findings drew on sample statistics derived from 
patient distributions for each separate inpatient setting 
stratified by age category and modified Rankin Scale 
score, and their results were driven by assuming more 
severe stroke survivors received ESD. What our study adds 
is that when comparing ESD and non- ESD patient groups 
matched for important patient characteristics, receiving 
ESD does not relate to a reduction in length of hospital 
stay.
Another important consideration is that average length 
of hospital stay for stroke survivors overall has reduced 
dramatically over the last 20 years, the latter decade of 
which our study captures between the two cohorts in this 
paper (ie, 2013–2014 and 2015–2016).13 This makes it less 
likely for an intervention like ESD to have an effect (in 
comparison to the years 1997–2004 when the original UK 
clinical trials were conducted).2 That ESD in this study 
was associated with an average increase in length of stay of 
1 day could be interpreted as the need for additional time 
to facilitate the transfer of care to the ESD team, rather 
than stroke survivors simply leaving hospital without 
support (if ESD was not available). Previous studies have 
also highlighted transfer problems relating to lack of 
joint working between health and social care.29–31 Our 
parallel paper added to this debate by highlighting the 
importance of access to a social worker as part of the ESD 
team.15
What was not possible to investigate in this study was 
whether access to ESD (despite an additional day in 
hospital) was associated with improved patient outcomes 
over the longer term. Recent observational studies in 
Sweden suggest patient and caregiver benefits related 
to provision of ESD in regular clinical practice, in line 
with our previous study findings from England.32 33 We 
suggest routine collection of additional validated patient 
outcome measures (eg, measuring activities of daily 
Table 3 Matched analysis between patients who received ESD on the care pathway and similar patients who did not 2015–
2016*
Inpatient matching models Between† Within†
Patients 30 791 (8593 ESD+22 198 non- ESD) 10 449 (4572 ESD+5877 non- ESD)
Admitting hospitals 55 14
ESD on the care pathway Coefficient (95% CI) P value Coefficient (95% CI) P value
Received ESD 0.07 (0.03 to 0.11) <0.001 0.08 (0.05 to 0.12) <0.001
Model coefficients are on the natural log scale; significant results were back- transformed, that is, exponentiated to obtain percentage 
difference in length of hospital stay (reported in text).
*This is a sensitivity analysis using propensity score matching to complement the multilevel model results presented in table 2. Between 
means patients in all hospitals were matched even if the hospitals did not offer ESD, whereas within means only hospitals with patients who 
did and did not receive ESD were matched.
†Adjusted for age, sex, prestroke independence, comorbidities, NIHSS score on admission, type of stroke and modified Rankin Scale score 
at discharge from hospital (patient level).
ESD, early supported discharge; NIHSS, National Institutes of Health Stroke Scale.
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living, general health/mood and quality of life) at longer 
follow- up periods in national stroke audits or registries is 
required.2 34 35
Like other observational studies, this study had its limita-
tions. Although numbers of patients were sufficient for 
the analysis undertaken, by focusing on specific regions 
of England, transferability of findings could be ques-
tioned, particularly outside England. Other limitations 
include potential sources of residual confounding and 
also reliance on SSNAP data being accurately reported 
by hospital teams. Length of hospital stay data are inher-
ently variable, and while we tried to include a proxy 
measure for other sources of delays in discharge, analysis 
would have benefited from social care related patient 
level variables.28 32 Patients also experienced a series of 
hospital stays (eg, transfer between acute and rehabil-
itation wards), relying on accurate transfer of SSNAP 
records between hospitals and resulting in us focusing on 
total length of hospital stay and ESD provision on a care 
pathway.36 What this means is that the impact of ESD on a 
particular hospital may not be apparent, which may be of 
more interest to providers of hospital services.
CONCLUSION
Original clinical trials of ESD were conducted across the 
world, and implementation of ESD is recommended in 
many countries’ stroke guidelines.4–9 This study inves-
tigated the impact of ESD in real- world settings and 
focused on length of hospital stay. ESD was not associ-
ated with a reduction in length of hospital stay as previ-
ously reported in clinical trials, although the increased 
average length of stay was just 1 day. This highlights the 
importance of investigating whether trial- based outcomes 
of interventions are realised in the real world. What 
Table 4 Patient characteristics from 2013 to 2014 and from 
2015 to 2016 cohorts
Patient 
characteristics ESD (n=11 376) Non- ESD (n=39 417)
Age, years
  <60 1847 (16.2) 6212 (15.8)
  60–69 2239 (19.7) 6647 (16.9)
  70–79 3467 (30.5) 10 543 (26.8)
  80–89 3126 (27.5) 12 087 (30.7)
  >89 697 (6.1) 3928 (10.0)
Gender
  Male 6352 (55.8) 19 959 (50.6)
Already inpatient at 
time of stroke
  Yes 361 (3.2) 1766 (4.5)
Congestive heart 
failure prior to 
admission
  Yes 481 (4.2) 1558 (4.0)
Hypertension prior to 
admission
  Yes 6261 (55.0) 21 313 (54.1)
Atrial fibrillation prior 
to admission
  Yes 1840 (16.2) 7299 (18.5)
Diabetes prior to 
admission
  Yes 2345 (20.6) 8074 (20.5)
Stroke/TIA prior to 
admission
  Yes 2740 (24.1) 10 482 (26.6)
Modified Rankin 
Scale score before 
stroke
  0 7389 (65.0) 22 847 (58.0)
  >0 3987 (35.1) 16 570 (42.0)
NIHSS score on 
arrival
  0 1430 (12.6) 6884 (17.5)
  1–5 6020 (52.9) 18 802 (47.7)
  6–14 2955 (26.0) 9162 (23.2)
  15–24 861 (7.6) 3833 (9.7)
  >24 110 (1.0) 736 (1.9)
Type of stroke
  Infarction 10 315 (91.2) 35 989 (92.1)
  Primary 
intracerebral 
haemorrhage
998 (8.8) 3079 (7.9)
Modified Rankin 
Scale score at 
inpatient discharge
  0 1440 (12.7) 8474 (21.5)
Continued
Patient 
characteristics ESD (n=11 376) Non- ESD (n=39 417)
  1 2928 (25.7) 8649 (21.9)
  2 2562 (22.5) 5456 (13.8)
  3 2817 (24.8) 6090 (15.5)
  4 1471 (12.9) 6733 (17.1)
  5 158 (1.4) 4015 (10.2)
Time period
  2013–2014 3065 (26.9) 21 841 (55.4)
  2015–2016 8311 (73.1) 17 576 (44.6)
Median (IQR) total 
length of hospital stay 
in days
  2013–2014 7.7 (3.2–23.8) 6.3 (2.5–22.1)
  2015–2016 6.8 (2.9–18.5) 5.7 (2.1–24.6)
Values are numbers (percentages) unless stated otherwise.
NIHSS, National Institutes of Health Stroke Scale; TIA, transient 
ischemic attack.
Table 4 Continued
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remains to be investigated and reported are the benefits 
of accessing ESD over the longer term. Also by focusing 
analysis on patients who would have been eligible, but did 
not receive ESD, we have highlighted an important gap in 
service provision.
Acknowledgements We would like to thank the many people and organisations 
participating in Sentinel Stroke National Audit Programme (SSNAP) and members 
of the SSNAP collaboration. We would also like to thank Trevor Gard and Frances 
Cameron, stroke survivors who were members of our study steering group.
Contributors All named authors made a substantial contribution across a 
number of areas including study design, data analysis, interpretation of findings, 
drafting/revising the manuscript and approving the final version for publication. 
All authors agree to be accountable for respective aspects of the work ensuring 
that questions related to the accuracy or integrity of any part of the work are 
appropriately investigated and resolved. RF (principal investigator) led in the 
original design of the study protocol, with input from MW, SL, TR, PL, AB and NC. 
LP, AH and AR are SSNAP collaborators and advised on access to audit data and 
appropriate use for research purposes. RF led running of the study, with AB and SL 
leading on statistical methodology, obtaining data from SSNAP, data analysis and 
interpretation, and article writing and approval; NC, MW, TR and PL advised RF on 
overall study design, data interpretation, article writing and approval; LP, AH and AR 
are SSNAP collaborators and were involved in data sharing agreements, advice on 
data handling, analysis, article writing and approval.
Funding This research was funded by the National Institute for Health Research 
(NIHR), Health Services and Delivery Research (HS&DR) Programme (16/01/17). 
RF is funded by the Stroke Association (TSA LECT 2016/01 Stroke Association 
HRH the Princess Margaret Senior Lecturer Award). TR is an NIHR senior 
investigator. The SSNAP is commissioned by the Healthcare Quality Improvement 
Partnership and funded by National Health Service England and the Welsh 
Government.
Disclaimer The views expressed are those of the authors and not necessarily 
those of the NHS, the NIHR or the Department of Health and Social Care.
Competing interests None declared.
Patient and public involvement Patients and/or the public were involved in the 
design, or conduct, or reporting, or dissemination plans of this research. Refer to 
the Methods section for further details.
Patient consent for publication Not required.
Ethics approval The study protocol was approved by the University of Nottingham 
Ethics Committee and the UK Healthcare Quality Improvement Partnership Data 
Access Request Group.
Data availability statement Data may be obtained from a third party and are 
not publicly available. Data access requests should be directed to the Healthcare 
Quality Improvement Partnership as the data controller and the Sentinel Stroke 
National Audit Programme as the data provider.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
ORCID iD
Adrian Byrne http:// orcid. org/ 0000- 0003- 4887- 2572
REFERENCES
 1 Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. The 
Lancet 2011;377:1693–702.
 2 Langhorne P, Baylan S, Early Supported Discharge Trialists. Early 
supported discharge services for people with acute stroke. Cochrane 
Database Syst Rev 2017;7:CD000443.
 3 Intercollegiate Stroke Working Party. National clinical guideline for 
stroke. 5th ed. London: Royal College of Physicians, 2016.
 4 The National Institute for Health and Care Excellence. Stroke 
rehabilitation in adults. NICE guidelines (clinical guideline CG 162); 
2013.
 5 The European Stroke Organization (ESO) Executive Committee 
and the ESO Writing Committee. Guidelines for management of 
ischaemic stroke and transient ischaemic attack 2008. Available: 
http://www. congrex- switzerland. com/ fileadmin/ files/ 2013/ eso- 
stroke/ pdf/ ESO08_ Guidelines_ Original_ english. pdf [Accessed 28 
Aug 2019].
 6 Adeoye O, Nyström KV, Yavagal DR, et al. Recommendations for 
the establishment of stroke systems of care: a 2019 update. Stroke 
2019;50:e187–210.
 7 Hebert D, Lindsay MP, McIntyre A, et al. Canadian stroke best 
practice recommendations: stroke rehabilitation practice guidelines, 
update 2015. Int J Stroke 2016;11:459–84.
 8 Stroke Foundation. Clinical guidelines for stroke management, 2019. 
Available: https:// informme. org. au/ en/ Guidelines/ Clinical- Guidelines- 
for- Stroke- Management [Accessed 28 Aug 2019].
Table 5 Association between having received ESD on the care pathway and inpatient length of stay 2013–2016
Inpatient length of stay models Unadjusted Adjusted*
Patients 49 667 49 266
Admitting hospitals 41 41




Intraclass correlation coefficient 0.04 0.08
ESD on the care pathway Coefficient (95% CI) P value Coefficient (95% CI) P value
Received ESD 0.14 (0.09 to 0.20) <0.001 0.17 (0.13 to 0.22) <0.001
2015–2016 time period −0.06 (-0.09 to -0.04) <0.001 −0.15 (-0.17 to -0.13) <0.001
Received ESD * 2015–2016 time period −0.05 (–0.11 to 0.02) 0.162 0.01 (–0.04 to 0.06) 0.790
Model coefficients are on the natural log scale; significant results were back- transformed, that is, exponentiated to obtain percentage change 
in length of hospital stay (reported in text).
*Adjusted for age, sex, prestroke independence, comorbidities, NIHSS score on admission, type of stroke and modified Rankin Scale score at 
discharge from hospital (patient level); ASCOF rate and hospital SSNAP rating score (admitting hospital level).
ASCOF, Adult Social Care Outcomes Framework; ESD, early supported discharge; NIHSS, National Institutes of Health Stroke Scale; SSNAP, 
Sentinel Stroke National Audit Programme.









pen: first published as 10.1136/bm




9Fisher RJ, et al. BMJ Open 2021;11:e043480. doi:10.1136/bmjopen-2020-043480
Open access
 9 Kings College London for the Stroke Alliance for Europe. The burden 
of stroke in Europe report, 2017. Available: https:// strokeeurope. 
eu/ index/ rehabilitation- and- long- term- support/ 5- 4early- supported- 
discharge/ [Accessed 28 Aug 2019].
 10 Sentinel Stroke National Audit Programme (SSNAP). Post- Acute 
organisational audit. phase 2: organisational audit of post- acute 
stroke service providers, 2015. Available: https://www. strokeaudit. 
org/ results/ Organisational. aspx [Accessed 15 Mar 2019].
 11 Saka O, Serra V, Samyshkin Y, et al. Cost- Effectiveness of stroke unit 
care followed by early supported discharge. Stroke 2009;40:24–9.
 12 Neale S, Leach K, Steinfort S, et al. Costs and length of stay 
associated with early supported discharge for moderate and severe 
stroke survivors. J Stroke Cerebrovasc Dis 2020;29:e104996:104996.
 13 Sentinel Stroke National Audit Programme. National clinical results, 
2018-2019. Available: https://www. strokeaudit. org/ results/ Clinical- 
audit/ National- Results. aspx [Accessed 8 Jun 2020].
 14 Rudd AG, Hoffman A, Paley L, et al. 20 years of researching stroke 
through audit. Clin Rehabil 2018;32:997–1006.
 15 Fisher RJ, Byrne A, Chouliara N, et al. Effectiveness of stroke early 
supported discharge: analysis from a national stroke Registry. Circ 
Cardiovasc Qual Outcomes 2020;13:e006395.
 16 Fisher R, Chouliara N, Byrne A, et al. What is the impact of large- 
scale implementation of stroke early supported discharge? a mixed 
methods realist evaluation study protocol. Implement Sci 2019;14:61.
 17 NHS Midlands and East. NHS Midlands and East stroke service 
specification, 2012. Available: https://www. england. nhs. uk/ mids- 
east/ wp- content/ uploads/ sites/ 7/ 2018/ 03/ final- stroke- spec. pdf 
[Accessed 15 Mar 2019].
 18 Sentinel Stroke National Audit Programme. A guide to therapy data, 
2017. Available: https:// ssnap. zendesk. com/ hc/ en- us/ articles/ 
360001955854- Download- fullpack- of- Therapy- Report [Accessed 6 
Mar 2019].
 19 Sentinel Stroke National Audit Programme. National clinical results, 
2016. Available: https://www. strokeaudit. org/ results/ Clinical- audit/ 
National- Results. aspx [Accessed 6 Mar 2019].
 20 Department of Health. Measures from the adult social care outcomes 
framework, England, 2015-2016. Available: https:// digital. nhs. uk/ 
data- and- information/ publications/ statistical/ adult- social- care- 
outcomes- framework- ascof [Accessed 6 Mar 2019].
 21 Turner M, Barber M, Dodds H, et al. Implementing a simple care 
bundle is associated with improved outcomes in a national cohort of 
patients with ischemic stroke. Stroke 2015;46:1065–70.
 22 Teale EA, Forster A, Munyombwe T, et al. A systematic review 
of case- mix adjustment models for stroke. Clin Rehabil 
2012;26:771–86.
 23 Raine R, Fitzpatrick R, Barratt H, et al. Challenges, solutions and 
future directions in the evaluation of service innovations in health 
care and public health. Health Serv Deliv Res 2016;4:1–136.
 24 Morris S, Hunter RM, Ramsay AIG, et al. Impact of centralising 
acute stroke services in English metropolitan areas on mortality 
and length of hospital stay: difference- in- differences analysis. BMJ 
2014;349:g4757.
 25 Rafferty A, Walthery P, King- Hele S. Analysing change over time: 
repeated cross sectional and longitudinal survey data UK Data 
Service, University of Essex and University of Manchester; 2015.
 26 Propensity score matching in Stata using teffects, 2015. Available: 
https://www. ssc. wisc. edu/ sscc/ pubs/ stata_ psmatch. htm [Accessed 
28 Nov 2019].
 27 Sekhon JS. Multivariate and Propensity Score Matching Software 
with Automated Balance Optimization: The Matching Package for R. 
J Stat Softw 2011;42:1–52.
 28 Sentinel stroke national audit programme: cost and cost- 
effectiveness analysis. Available: https://www. strokeaudit. org/ 
SupportFiles/ Documents/ Health- Economics/ Health- economic- 
report- 2016. aspx [Accessed 8 Jun 2020].
 29 Cobley CS, Fisher RJ, Chouliara N, et al. A qualitative study 
exploring patients' and carers' experiences of early supported 
discharge services after stroke. Clin Rehabil 2013;27:750–7.
 30 Chouliara N, Fisher RJ, Kerr M, et al. Implementing evidence- based 
stroke early supported discharge services: a qualitative study of 
challenges, facilitators and impact. Clin Rehabil 2014;28:370–7.
 31 Swinkels A, Mitchell T. Delayed transfer from hospital to community 
settings: the older person's perspective. Health Soc Care Community 
2009;17:45–53.
 32 Tistad M, von Koch L. Usual clinical practice for early supported 
discharge after stroke with continued rehabilitation at home: an 
observational comparative study. PLoS One 2015;10:e0133536.
 33 Bråndal A, Eriksson M, Glader E- L, et al. Effect of early supported 
discharge after stroke on patient reported outcome based on the 
Swedish Riksstroke registry. BMC Neurol 2019;19:40.
 34 Fisher RJ, Gaynor C, Kerr M, et al. A consensus on stroke: early 
supported discharge. Stroke 2011;42:1392–7.
 35 Fisher RJ, Cobley CS, Potgieter I, et al. Is stroke early supported 
discharge still effective in practice? A prospective comparative study. 
Clin Rehabil 2016;30:268–76.
 36 Gittins M, Lugo- Palacios DG, Paley L, et al. How do patients pass 
through stroke services? identifying stroke care pathways using 
national audit data. Clin Rehabil 2020;34:698–709.









pen: first published as 10.1136/bm
jopen-2020-043480 on 20 January 2021. D
ow
nloaded from
 
